These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35972839)

  • 21. Novel N-benzylpyridinium moiety linked to arylisoxazole derivatives as selective butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study.
    Vafadarnejad F; Karimpour-Razkenari E; Sameem B; Saeedi M; Firuzi O; Edraki N; Mahdavi M; Akbarzadeh T
    Bioorg Chem; 2019 Nov; 92():103192. PubMed ID: 31446239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, molecular docking and biological evaluation of N,N-disubstituted 2-aminothiazolines as a new class of butyrylcholinesterase and carboxylesterase inhibitors.
    Makhaeva GF; Boltneva NP; Lushchekina SV; Serebryakova OG; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Bachurin SO; Richardson RJ
    Bioorg Med Chem; 2016 Mar; 24(5):1050-62. PubMed ID: 26827140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, structural characterization, docking, lipophilicity and cytotoxicity of 1-[(1R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]-3-alkyl carbamates, novel acetylcholinesterase and butyrylcholinesterase pseudo-irreversible inhibitors.
    Pejchal V; Štěpánková Š; Pejchalová M; Královec K; Havelek R; Růžičková Z; Ajani H; Lo R; Lepšík M
    Bioorg Med Chem; 2016 Apr; 24(7):1560-72. PubMed ID: 26947959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New piperidine-hydrazone derivatives: Synthesis, biological evaluations and molecular docking studies as AChE and BChE inhibitors.
    Karaman N; Sıcak Y; Taşkın-Tok T; Öztürk M; Karaküçük-İyidoğan A; Dikmen M; Koçyiğit-Kaymakçıoğlu B; Oruç-Emre EE
    Eur J Med Chem; 2016 Nov; 124():270-283. PubMed ID: 27592396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring 3-Benzyloxyflavones as new lead cholinesterase inhibitors: synthesis, structure-activity relationship and molecular modelling simulations.
    Mughal EU; Sadiq A; Ayub M; Naeem N; Javid A; Sumrra SH; Zafar MN; Khan BA; Malik FP; Ahmed I
    J Biomol Struct Dyn; 2021 Oct; 39(16):6154-6167. PubMed ID: 32752941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and molecular modelling of thiadizole based hydrazone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitory activities.
    Işık A; Acar Çevik U; Karayel A; Celik I; Erçetin T; Koçak A; Özkay Y; Kaplancıklı ZA
    SAR QSAR Environ Res; 2022 Mar; 33(3):193-214. PubMed ID: 35243936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, structure-activity relationship and molecular docking studies of 3-O-flavonol glycosides as cholinesterase inhibitors.
    Mughal EU; Javid A; Sadiq A; Murtaza S; Zafar MN; Khan BA; Sumrra SH; Tahir MN; Kanwal ; Khan KM
    Bioorg Med Chem; 2018 Jul; 26(12):3696-3706. PubMed ID: 29886083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SAR based in-vitro anticholinesterase and molecular docking studies of nitrogenous progesterone derivatives.
    Amin MJ; Miana GA; Rashid U; Rahman KM; Khan HU; Sadiq A
    Steroids; 2020 Jun; 158():108599. PubMed ID: 32126219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A New Class of Benzo[
    Delogu GL; Begala M; Matos MJ; Crucitti D; Sogos V; Era B; Fais A
    Molecules; 2024 Aug; 29(16):. PubMed ID: 39202830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.
    Mutahir S; Jończyk J; Bajda M; Khan IU; Khan MA; Ullah N; Ashraf M; Qurat-ul-Ain ; Riaz S; Hussain S; Yar M
    Bioorg Chem; 2016 Feb; 64():13-20. PubMed ID: 26595185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, characterization, molecular docking, dynamics simulations, and
    Işık A; Çevik UA; Celik I; Erçetin T; Koçak A; Özkay Y; Kaplancıklı ZA
    Z Naturforsch C J Biosci; 2022 Nov; 77(11-12):447-457. PubMed ID: 35599239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis, and biological evaluation of ferulic acid based 1,3,4-oxadiazole hybrids as multifunctional therapeutics for the treatment of Alzheimer's disease.
    Tripathi A; Choubey PK; Sharma P; Seth A; Saraf P; Shrivastava SK
    Bioorg Chem; 2020 Jan; 95():103506. PubMed ID: 31887472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, characterization, evaluation of metabolic enzyme inhibitors and in silico studies of thymol based 2-amino thiol and sulfonic acid compounds.
    Bora RE; Genc Bilgicli H; Üç EM; Alagöz MA; Zengin M; Gulcin İ
    Chem Biol Interact; 2022 Oct; 366():110134. PubMed ID: 36057360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, molecular docking studies, and biological evaluation of novel alkyl bis(4-amino-5-cyanopyrimidine) derivatives.
    Boualia I; Derabli C; Boulcina R; Bensouici C; Yildirim M; Birinci Yildirim A; Mokrani EH; Debache A
    Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900027. PubMed ID: 31448454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, characterization and biological screening of 5-substituted-1,3,4-oxadiazole-2yl-N-(2-methoxy-5-chlorophenyl)-2-sulfanyl acetamide.
    Rehman A; Fatima A; Abbas N; Abbasi MA; Khan KM; Ashraf M; Ahmad I; Ejaz SA
    Pak J Pharm Sci; 2013 Mar; 26(2):345-52. PubMed ID: 23455206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1,2,3-Triazolo[4,5-b]aminoquinolines: Design, synthesis, structure, acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitory activity, and molecular docking of novel modified tacrines.
    Kappenberg YG; Nogara PA; Stefanello FS; Delgado CP; Rocha JBT; Zanatta N; Martins MAP; Bonacorso HG
    Bioorg Chem; 2023 Oct; 139():106704. PubMed ID: 37453239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-silico identification of the binding mode of synthesized adamantyl derivatives inside cholinesterase enzymes.
    Al-Aboudi A; Al-Qawasmeh RA; Shahwan A; Mahmood U; Khalid A; Ul-Haq Z
    Acta Pharmacol Sin; 2015 Jul; 36(7):879-86. PubMed ID: 25937631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, structure-activity relationship and molecular docking of 3-oxoaurones and 3-thioaurones as acetylcholinesterase and butyrylcholinesterase inhibitors.
    Mughal EU; Sadiq A; Murtaza S; Rafique H; Zafar MN; Riaz T; Khan BA; Hameed A; Khan KM
    Bioorg Med Chem; 2017 Jan; 25(1):100-106. PubMed ID: 27780618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multipotent Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease: Synthesis, Biological Analysis and Molecular Docking Study of Benzimidazole-Based Thiazole Derivatives.
    Hussain R; Ullah H; Rahim F; Sarfraz M; Taha M; Iqbal R; Rehman W; Khan S; Shah SAA; Hyder S; Alhomrani M; Alamri AS; Abdulaziz O; Abdelaziz MA
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydrazone-sulfonate hybrids as potential cholinesterase inhibitors: design, synthesis and molecular modeling simulation.
    Omar MA; El-Shiekh RA; Dawood DH; Temirak A; Srour AM
    Future Med Chem; 2023 Dec; 15(24):2269-2287. PubMed ID: 37994559
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.